SC 13G Filing

Company

ROCKET PHARMACEUTICALS, INC.

Filed

January 16, 2018

Accession Number

0001214659-18-000437

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →